A Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite ®
Condition: Schizophrenia Intervention: Combination Product: ABILIFY MYCITE Sponsor: Otsuka Pharmaceutical Development& Commercialization, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials